Autoimmune hepatitis in southern Israel: A 15-year multicenter study

Journal of Digestive Diseases

Volumn 14, Issue 11, 2013, Pages 611-618

  Delgado, Jorge Shmuel ^a   Vodonos, Alina ^a   Malnick, Stephen ^c   Kriger, Ofra ^d   Wilkof Segev, Renana ^a   Delgado, Bertha ^e   Novack, Victor ^a   Rosenthal, Alexander ^b   Menachem, Yoram ^e   Melzer, Ehud ^c   Fich, Alexander ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e Clalit Medical Services   (Israel)

Author keywords

Autoimmune hepatitis; Epidemiology; Israel; Outcome; Therapy

Indexed keywords

AZATHIOPRINE; BUDESONIDE; PREDNISONE;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; COMBINATION CHEMOTHERAPY; DRUG INTOXICATION; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HUMAN TISSUE; ISRAEL; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SURVIVAL RATE; TREATMENT RESPONSE;

AUTOIMMUNE HEPATITIS; EPIDEMIOLOGY; ISRAEL; OUTCOME; THERAPY;

ADULT; AZATHIOPRINE; BIOPSY; BUDESONIDE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; ISRAEL; LIVER; MALE; MIDDLE AGED; PREDNISONE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84884919981     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12085     Document Type: Article

References (28)

1. Manns MP, Czaja AJ, Gorham JD etal; American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-2213.
2. Gleeson D, Heneghan MA; British Society of Gastroenterology. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut 2011; 60: 1611-1629.
3. Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 2010; 139: 58-72.e4.
4. Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 2002; 6: 635-647.
5. Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun 2010; 34: J300-306.
6. Choudhuri G, Somani SK, Baba CS, Alexander G. Autoimmune hepatitis in India: profile of an uncommon disease. BMC Gastroenterol 2005; 5: 27.
7. Lee YM, Teo EK, Ng TM, Khor C, Fock KM. Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women. J Gastroenterol Hepatol 2001; 16: 1384-1389.
8. Koay LB, Lin CY, Tsai SL etal. Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International Autoimmune Hepatitis Group. Dig Dis Sci 2006; 51: 1978-1984.
9. Haider AS, Kaye G, Thomson A. Autoimmune hepatitis in a demographically isolated area of Australia. Intern Med J 2010; 40: 281-285.
10. Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol 2002; 97: 2402-2407.
11. Ngu JH, Bechly K, Chapman BA etal. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol 2010; 25: 1681-1686.
12. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33: 99-103.
13. Werner M, Prytz H, Ohlsson B etal. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol 2008; 43: 1232-1240.
14. Primo J, Merino C, Fernández J, Molés JR, Llorca P, Hinojosa J. Incidence and prevalence of autoimmune hepatitis in the area of the Hospital de Sagunto (Spain). Gastroenterol Hepatol 2004; 27: 239-243 (in Spanish).
15. Hennes EM, Zeniya M, Czaja AJ etal; International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176.
16. Boberg KM, Chapman RW, Hirschfield GM etal; International Autoimmune Hepatitis Group. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011; 54: 374-385.
17. Summerskill WH, Korman MG, Ammon HV, Baggenstoss AH. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 1975; 16: 876-883.
18. Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 2006; 45: 575-583.
19. Montano-Loza AJ, Carpenter HA, Czaja AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology 2007; 46: 1138-1145.
20. Al-Chalabi T, Underhill JA, Portmann BC, McFarlane IG, Heneghan MA. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol 2008; 48: 140-147.
21. Muratori P, Granito A, Quarneti C etal. Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol 2009; 50: 1210-1218.
22. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996; 110: 848-857.
23. van Gerven NM, Verwer BJ, Witte BI etal; Dutch Autoimmune Hepatitis Working Group. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol 2013; 58: 141-147.
24. Zolfino T, Heneghan MA, Norris S, Harrison PM, Portmann BC, McFarlane IG. Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Gut 2002; 50: 713-717.
25. Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology 2007; 46: 1828-1835.
26. Minuk GY, Liu S, Kaita K etal. Autoimmune hepatitis in a North American Aboriginal/First Nations population. Can J Gastroenterol 2008; 22: 829-834.
27. Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. The impact of race/ethnicity on the clinical epidemiology of autoimmune hepatitis. J Clin Gastroenterol 2012; 46: 155-161.
28. Lim KN, Casanova RL, Boyer TD, Bruno CJ. Autoimmune hepatitis in African Americans: presenting features and response to therapy. Am J Gastroenterol 2001; 96: 3390-3394.